Keywords: Angelini, Labopharm, Oleptro, Major despressive disorder, US launch

Angelini Labopharm launch of Oleptro in USA for major depressive disorder in adults

Article | 10 August 2010

Angelini Labopharm announced yesterday that its antidepressant Oleptro (trazodone hydrochloride extended-release tablets), a novel once-daily formulation, is now commercially available ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Labopharm

Angelini

Go to company listing

Related Drugs

Oleptro

Go to drug listing